Article 38 — Reports — compare

Showing 5 of 5Release 1 Nov 2026Details

Coverage: MAR: every English consolidation from 1 Jan 2021. Older wording is not held and is not replaced by any other text. Not covered: national guidance, court decisions.
Freshness: Release a4f2a049 published 1 Nov 2026, 17:41 CET. This article checked word for word against EUR-Lex on 26 Oct 2026.
Shown: Showing 5 of 5
Failures: None.
Incomplete: No.

From: 4 December 2024 · Consolidated version of 4 December 2024 · Checked against EUR-Lex on 1 Nov 2026 · Official source
To: 2 November 2026 · Consolidated version of 5 June 2026 · Checked against EUR-Lex on 1 Nov 2026 · Official source

1.By 5 December 2028, the Commission shall submit a report to the European Parliament and to the Council on the application of this Regulation, together with a legislative proposal to amend it if appropriate. That report shall assess, inter alia:

38(1)(c)

(c)whether the provision on non-disclosure of inside information relating to intermediate steps in a protracted process in Article 17(1) strikes an adequate balance between reducing the burden for issuers and allowing investors to take informed investment decisions; and

38(1)(d)

(d)the proportionality of the absolute amounts, as expressed in Article 30(2), points (j)(iii) and (iv), and their appropriateness in relation to micro, small and medium-sized enterprises.

By 5 December 2031, the Commission shall submit a report to the European Parliament and to the Council on the functioning of the cross-market order data surveillance mechanism, its impact on the ability of national competent authorities to ensure effective supervision, how to enforce such mechanism, and the merits of the potential inclusion of systematic internalisers in the scope of the mechanism.

By 5 December 2028, the Commission shall, after consulting ESMA, submit a report to the European Parliament and to the Council on the level of the thresholds set out in Article 19(1a), points (a) and (b), in relation to managers’ transactions where the issuer’s shares or debt instruments form part of a collective investment undertaking or provide exposure to a portfolio of assets, with a view to assessing whether that level is appropriate or should be adjusted.

Rest of the article unchanged · show